X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 44c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. RXRX

Go back to X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 44c

X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

May 6, 2021 8:00 AM EDT

Company continues to make significant clinical progress with lead candidate mavorixafor across multiple rare disease indications

Enrollment update on Phase 3 WHIM trial expected in mid-2021

Initial data from ongoing Phase 1b trial in Waldenströms macroglobulinemia to be presented at EHA Meeting in June 2021

Conference call today at 8:30 a.m. ET

BOSTON, May 06, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq:... More